• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

asthma

GSK
Pharma

GSK used Flovent generic partner to 'game the system': senator

A report from Sen. Maggie Hassan lays out how GSK avoided paying Medicaid rebates and retained its monopoly on its asthma inhaler Flovent.
Kevin Dunleavy Mar 17, 2026 5:05pm
Glenmark RD center in Nashik India

Glenmark gains FDA nod for first 'true' generic of GSK's Flovent

Mar 5, 2026 12:40pm
Brinsupri

Insmed forecasts sales of Brinsupri will reach $1B in 2026

Feb 19, 2026 11:45am
GSK London

GSK scoops up yet another FDA approval, this time in asthma

Dec 17, 2025 8:30am
Traffic light go start restart green light

GSK's long-acting asthma med wins CHMP backing

Dec 12, 2025 11:27am
AZ

AstraZeneca adds $136M investment to Chinese inhalants facility

Nov 5, 2025 11:14am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings